Literature DB >> 25814288

LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells.

Yurong Zhang1, Qin Luo, Ning Wang, Fangyuan Hu, Haojie Jin, Tianxiang Ge, Cun Wang, Wenxin Qin.   

Abstract

Hepatocellular carcinoma (HCC) is a malignant tumor driven by complex pathological mechanisms and is characterized by fast progression and poor prognosis. The main cause of death in HCC patients is tumor metastasis. However, underlying molecular mechanisms of metastasis are largely unknown in HCC. In the present study, a novel metastasis-related gene, leucine-rich-alpha-2-glycoprotein 1 (LRG1), was identified in HCC. We revealed that LRG1 expression was downregulated in HCC tissues by quantitative real-time PCR and immunohistochemical staining. In vitro assays demonstrated LRG1 had no effect on cell proliferation. Migratory and invasive potential of HCC cells was reduced by ectopic overexpression of LRG1, whereas silencing LRG1 could enhance migration and invasion of HCC cells. Furthermore, exogenous recombinant human protein of LRG1 could inhibit migration and invasion of HCC cells in vitro. The above findings indicate that LGR1 is involved in the inhibition of HCC metastasis and it may function as a novel metastasis suppressor in HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25814288     DOI: 10.1007/s12032-015-0598-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

1.  Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.

Authors:  Satoshi Serada; Minoru Fujimoto; Fumitaka Terabe; Hideki Iijima; Shinichiro Shinzaki; Shinya Matsuzaki; Tomoharu Ohkawara; Riichiro Nezu; Sachiko Nakajima; Taku Kobayashi; Scott Eric Plevy; Tetsuo Takehara; Tetsuji Naka
Journal:  Inflamm Bowel Dis       Date:  2012-02-28       Impact factor: 5.325

2.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

Review 3.  Proteins with leucine-rich repeats.

Authors:  B Kobe; J Deisenhofer
Journal:  Curr Opin Struct Biol       Date:  1995-06       Impact factor: 6.809

4.  [Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's transl)].

Authors:  H Haupt; S Baudner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-06

Review 5.  Postoperative therapy options for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Liang Ma; Le-Qun Li
Journal:  Scand J Gastroenterol       Date:  2014-04-10       Impact factor: 2.423

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum.

Authors:  N Takahashi; Y Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

8.  Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.

Authors:  Yih-Huei Uen; Kai-Yuan Lin; Ding-Ping Sun; Chen-Chung Liao; Ming-Song Hsieh; Yung-Kai Huang; Yen-Wei Chen; Pei-Hsuan Huang; Wei-Jung Chen; Chih-Chun Tai; Kuan-Wei Lee; You-Chia Chen; Ching-Yu Lin
Journal:  J Proteomics       Date:  2013-03-26       Impact factor: 4.044

9.  Leucine-rich α2-glycoprotein is a novel biomarker of neurodegenerative disease in human cerebrospinal fluid and causes neurodegeneration in mouse cerebral cortex.

Authors:  Masakazu Miyajima; Madoka Nakajima; Yumiko Motoi; Masao Moriya; Hidenori Sugano; Ikuko Ogino; Eri Nakamura; Norihiro Tada; Miyuki Kunichika; Hajime Arai
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response.

Authors:  Ryoichi Shirai; Fumiyasu Hirano; Naoki Ohkura; Kiyoshi Ikeda; Seiji Inoue
Journal:  Biochem Biophys Res Commun       Date:  2009-03-24       Impact factor: 3.575

View more
  11 in total

1.  LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome.

Authors:  Diana E Ramirez-Ardila; Kirsten Ruigrok-Ritstier; Jean C Helmijr; Maxime P Look; Steven van Laere; Luc Dirix; Els M J J Berns; Maurice P H M Jansen
Journal:  Mol Oncol       Date:  2016-07-25       Impact factor: 6.603

Review 2.  The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors.

Authors:  Meng Lin; Jinmeng Liu; Fengping Zhang; Gaoxiu Qi; Shuqi Tao; Wenyuan Fan; Min Chen; Kang Ding; Fenghua Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-17       Impact factor: 4.553

3.  LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma.

Authors:  Chun-Hua Wang; Min Li; Li-Li Liu; Ruo-Yao Zhou; Jia Fu; Chris Zhiyi Zhang; Jing-Ping Yun
Journal:  Oncotarget       Date:  2015-12-08

4.  LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.

Authors:  Jingjing Zhang; Lingyin Zhu; Jingyuan Fang; Zhizheng Ge; Xiaobo Li
Journal:  J Exp Clin Cancer Res       Date:  2016-02-09

5.  LRG1 promotes angiogenesis through upregulating the TGF‑β1 pathway in ischemic rat brain.

Authors:  Hongmei Meng; Yuejia Song; Jiyuan Zhu; Qi Liu; Pengtian Lu; Na Ye; Zhen Zhang; Yuxin Pang; Jiping Qi; He Wu
Journal:  Mol Med Rep       Date:  2016-11-07       Impact factor: 2.952

6.  Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.

Authors:  Ming Keat Sng; Jeremy Soon Kiat Chan; Ziqiang Teo; Terri Phua; Eddie Han Pin Tan; Jonathan Wei Kiat Wee; Nikki Jun Ning Koh; Chek Kun Tan; Jia Peng Chen; Mintu Pal; Benny Meng Kiat Tong; Ya Lin Tnay; Xuan Rui Ng; Pengcheng Zhu; Shunsuke Chiba; Xiaomeng Wang; Walter Wahli; Nguan Soon Tan
Journal:  Cell Discov       Date:  2018-04-03       Impact factor: 10.849

7.  Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.

Authors:  Jiyoung Park; Yonghwan Choi; Junghyun Namkung; Sung Gon Yi; Hyunsoo Kim; Jiyoung Yu; Yongkang Kim; Min-Seok Kwon; Wooil Kwon; Do-Youn Oh; Sun-Whe Kim; Seung-Yong Jeong; Wonshik Han; Kyu Eun Lee; Jin Seok Heo; Joon Oh Park; Joo Kyung Park; Song Cheol Kim; Chang Moo Kang; Woo Jin Lee; Seungyeoun Lee; Sangjo Han; Taesung Park; Jin-Young Jang; Youngsoo Kim
Journal:  Oncotarget       Date:  2017-10-16

8.  Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis.

Authors:  De-Cong Sun; Yan Shi; Ling-Xiong Wang; Yao Lv; Quan-Li Han; Zhi-Kuan Wang; Guang-Hai Dai
Journal:  Oncotarget       Date:  2017-03-16

9.  MicroRNA-494 Inhibits the LRG1 Expression to Induce Proliferation and Migration of VECs in Rats following Myocardial Infarction.

Authors:  Qiang Su; Xiang-Wei Lv; Yu-Han Sun; Zi-Liang Ye; Bing-Hui Kong; Zhen-Bai Qin
Journal:  Mol Ther Nucleic Acids       Date:  2019-08-14       Impact factor: 8.886

Review 10.  LRG1: an emerging player in disease pathogenesis.

Authors:  Carlotta Camilli; Alexandra E Hoeh; Giulia De Rossi; Stephen E Moss; John Greenwood
Journal:  J Biomed Sci       Date:  2022-01-21       Impact factor: 12.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.